Literature DB >> 20853029

Combined therapy against murine-disseminated infection by Fusarium verticillioides.

Mery Ruíz-Cendoya1, Javier Pastor, Josep Guarro.   

Abstract

Using a murine model of disseminated infection by two strains of Fusarium verticillioides, we have evaluated the efficacy of high doses of amphotericin B (AMB) (3 mg/kg of body weight/day), voriconazole (VRC) (60 mg/kg of body weight/day), posaconazole (PSC) (100 mg/kg of body weight/day), and the combinations of AMB plus VRC or PSC. In general, our results were very modest. Neither combination was superior to the respective monotherapies. VRC alone and in combination with AMB was able to prolong survival but not to reduce tissue burden, and AMB plus PSC was able to reduce fungal load in organs but not to prolong survival.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20853029     DOI: 10.1007/s11046-010-9364-8

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  14 in total

1.  Successful treatment of disseminated fusariosis.

Authors:  C A Rodriguez; J Luján-Zilbermann; P Woodard; M Andreansky; E E Adderson
Journal:  Bone Marrow Transplant       Date:  2003-03       Impact factor: 5.483

2.  Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.

Authors:  Karl V Clemons; Marife Espiritu; Rachana Parmar; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 3.  Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management.

Authors:  E I Boutati; E J Anaissie
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

4.  Voriconazole treatment for less-common, emerging, or refractory fungal infections.

Authors:  John R Perfect; Kieren A Marr; Thomas J Walsh; Richard N Greenberg; Bertrand DuPont; Juliàn de la Torre-Cisneros; Gudrun Just-Nübling; Haran T Schlamm; Irja Lutsar; Ana Espinel-Ingroff; Elizabeth Johnson
Journal:  Clin Infect Dis       Date:  2003-04-22       Impact factor: 9.079

5.  Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.

Authors:  Issam I Raad; Ray Y Hachem; Raoul Herbrecht; John R Graybill; Roberta Hare; Gavin Corcoran; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2006-04-11       Impact factor: 9.079

Review 6.  Treating disseminated fusariosis: amphotericin B, voriconazole or both?

Authors:  Dora Y Ho; Jason D Lee; Fernando Rosso; Jose G Montoya
Journal:  Mycoses       Date:  2007-05       Impact factor: 4.377

7.  Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy.

Authors:  Anna Maria Tortorano; Anna Prigitano; Giovanna Dho; Maria Carmela Esposto; Claudia Gianni; Anna Grancini; Cristina Ossi; Maria Anna Viviani
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

Review 8.  Fusarium infections in immunocompromised patients.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

9.  Molecular phylogenetic diversity of dermatologic and other human pathogenic fusarial isolates from hospitals in northern and central Italy.

Authors:  Quirico Migheli; Virgilio Balmas; Henry Harak; Silvana Sanna; Barbara Scherm; Takayuki Aoki; Kerry O'Donnell
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

10.  Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation.

Authors:  Gulsum Tezcan; Betil Ozhak-Baysan; Ana Alastruey-Izquierdo; Dilara Ogunc; Gozde Ongut; Sinasi Taner Yildiran; Volkan Hazar; Manuel Cuenca-Estrella; Juan Luis Rodriguez-Tudela
Journal:  J Clin Microbiol       Date:  2008-11-12       Impact factor: 5.948

View more
  2 in total

Review 1.  Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment.

Authors:  J Guarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-11       Impact factor: 3.267

Review 2.  Successful treatment of disseminated fusariosis in a patient with acute lymphoblastic leukemia: A case report and literature review.

Authors:  Jieni Yu; Yan Chen; Jiabin Fang; Kejie Zhang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.